Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Ribonuclease R: Circular RNA Enrichment Workflow
2026-08-17
Use Ribonuclease R to reduce linear RNA background while preserving a topology-sensitive fraction enriched for circular transcripts. This practical workflow connects enzyme setup, circHIF1A validation, RNA structure analysis, and troubleshooting for more defensible circular RNA measurements.
-
Vincristine Sulfate: From Mechanism to Measurement
2026-08-17
Vincristine sulfate is a powerful microtubule-targeting tool for cancer research. This evidence-bound guide connects molecular mechanism, assay interpretation, product handling, and systematic-review methodology without overstating what the available evidence proves.
-
Trelagliptin, PI-3K/AKT, and Adipocyte Insulin Resistance
2026-08-16
The reference study examines how trelagliptin succinate affects insulin resistance in differentiated 3T3-L1 adipocytes, linking DPP-4 inhibition with PI-3K/AKT/GLUT4 signaling. Its findings associate trelagliptin treatment with enhanced insulin-pathway signaling and glucose uptake, alongside lower free fatty acid and resistin secretion, while the in vitro design limits causal and clinical interpretation.
-
Antimycin A4: ATP-Citrate Lyase Workflows
2026-08-15
Antimycin A4 is a dual-purpose research probe for separating ATP-citrate lyase activity from mitochondrial respiratory-chain effects. This practical guide covers biochemical assays, cell-based metabolic workflows, controls, storage, and troubleshooting for reproducible energy-metabolism experiments.
-
Anti-HMGB1 Rabbit Monoclonal Antibody
2026-08-14
Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 is intended for detecting HMGB1 protein in human, mouse, and rat research samples by Western blot, immunohistochemistry, and flow cytometry. It should be used as a research reagent only; the dossier does not support diagnostic, therapeutic, or paper-specific performance claims.
-
Quantifying Methylated Purine Nucleosides by UHPLC–MS/MS
2026-08-14
The reference study developed a stable isotope-diluted UHPLC–ESI-MS/MS workflow for measuring 12 purine ribonucleosides, including 10 methylated species such as 1-methyl Adenosine. Ammonium bicarbonate-enhanced ionization, chromatographic resolution of isomers, and methanol–SPE cleanup improved sensitivity sufficiently for intracellular measurements in 293T cells, supporting future RNA modification research and biomarker discovery.
-
Stiripentol as an LDH Inhibitor in Metabolic Research
2026-08-13
Stiripentol gives researchers a practical way to perturb LDH-dependent lactate and pyruvate flux while connecting seizure biology with emerging lactate-driven epigenetic assays. This workflow emphasizes formulation control, paired metabolic readouts, and careful separation of established epilepsy evidence from hypothesis-generating tumor immunometabolism applications.
-
Patient-Derived Gastric Cancer Assembloids
2026-08-13
This study develops patient-derived gastric cancer assembloids by combining matched tumor organoids with stromal subpopulations from the same tumor tissue. The model captures microenvironment-dependent changes in gene expression and drug response, creating a more physiologically relevant platform for tumor–stroma research and personalized treatment testing.
-
CCR7–Notch1 Crosstalk Drives Mammary Tumor Stemness
2026-08-12
Boyle and colleagues identify a functional signaling connection between CCR7 and Notch1 in primary MMTV-PyMT mammary cancer cells. Their perturbation-based experiments show that CCR7 stimulation activates Notch1 and that Notch inhibition suppresses CCR7-dependent stem-like behavior, providing a mechanistic rationale for studying both axes together.
-
ATRX Loss and RTK/PDGFR Sensitivity in Glioma
2026-08-12
The reference study shows that ATRX-deficient high-grade glioma cells are preferentially vulnerable to several multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its genotype-aware drug-screening strategy also identifies a stronger response when selected RTK inhibitors are combined with temozolomide, supporting ATRX status as a useful variable for preclinical design and clinical-trial interpretation.
-
N2-Alkyl-dG Lesions and R-Loop Accumulation
2026-08-11
The 2024 Nucleic Acids Research study identifies minor-groove N2-alkyl-dG lesions as a previously unrecognized trigger of R-loop accumulation in chromatin and plasmid DNA. By combining fluorescence microscopy, R-loop sequencing, genetic perturbation, and functional assays, the authors connect these lesions with transcription elongation defects, genome instability, and increased sensitivity to a carcinogenic alkylating agent.
-
Bacitracin B1670: Practical Research Guide
2026-08-11
Bacitracin B1670 is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis disruption. This guide covers dissolution, storage, assay controls, and troubleshooting; the material is for scientific research only and should not be used for diagnostic, clinical, or medical purposes.
-
Mestranol and Reversible Lysosomal Stress in Microglia
2026-08-10
A 2026 zebrafish study identifies mestranol as an inducer of a reversible lysosomal storage–like state in microglia. The work separates phagocytic uptake from intracellular digestion and provides a live model for investigating environmental estrogen-associated neuroimmunotoxicity.
-
DNase I for Translational RNA Workflow Control
2026-08-09
Mechanistic oncology is only as reliable as the nucleic-acid workflows used to validate it. This thought-leadership guide connects CAF-derived lactate, ANTXR1 lactylation, and oxaliplatin resistance with disciplined DNA removal, chromatin handling, and translational assay design using DNase I (RNase-free).
-
Chlorpromazine HCl for Endocytosis Assays
2026-08-08
Chlorpromazine HCl gives researchers a practical way to perturb clathrin-dependent uptake while preserving a well-established dopamine receptor antagonist profile. This guide translates infection-biology evidence into controlled cell assays, neuronal workflows, comparative controls, and troubleshooting decisions.